Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00065845 · ClinicalTrials.gov registry record · Phase 3
Colpopexy and Urinary Reduction Efforts (CARE) Protocol
A Phase 3 study of Uterine Prolapse and Vaginal Prolapse, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 3
- Development phase
- 322
- Enrollment target
- 7
- Study locations
NCT00065845 is a Phase 3 study of Uterine Prolapse and Vaginal Prolapse that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 322 participants, above the 149-participant average among 3 other Uterine Prolapse trials with a reported enrollment target (116% higher). The trial reports 7 study locations across 7 states.
The verdict
NCT00065845, a Phase 3 study of Uterine Prolapse and Vaginal Prolapse, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 322 participants
- Enrollment target
- 7
- Study locations
Study Summary
Pelvic organ prolapse occurs when the muscles holding pelvic organs (e.g., the uterus or bladder) weaken and the organs fall or slide down into the vagina. Pelvic organ prolapse can be corrected with surgery. However, women who have this surgery may develop urinary incontinence. This study will determine how doctors can predict this problem and whether an additional surgical procedure at the time of prolapse surgery can prevent the development of urinary incontinence.
Conditions Studied
Interventions
- PROCEDURE Burch urethropexy at time of sacrocolpopexy
Study Locations (7)
Alabama
- The University of Alabama at Birmingham - Birmingham
Illinois
- Loyola University Medical Center - Maywood
Iowa
- University of Iowa College of Medicine - Iowa City
Maryland
- Johns Hopkins School of Medicine - Baltimore
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Pennsylvania
- Magee-Womens Hospital - Pittsburgh
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2002-04 |
| Est. Completion | 2007-04 |
| Phase | Phase 3 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00065845
The ClinicalTrials.gov registry entry for NCT00065845 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 322 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 149-participant average among 3 other Uterine Prolapse trials with a reported enrollment target (116% higher). The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Uterine Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Burch urethropexy at time of sacrocolpopexy is the first listed.
NCT00065845 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Alabama, Illinois, Iowa.
Frequently Asked Questions
What is clinical trial NCT00065845 about?
NCT00065845 is a clinical study titled "Colpopexy and Urinary Reduction Efforts (CARE) Protocol". Pelvic organ prolapse occurs when the muscles holding pelvic organs (e.g., the uterus or bladder) weaken and the organs fall or slide down into the vagina. Pelvic organ prolapse can be corrected with surgery. However, women who have this surgery may develop urinary incontinence. This study will dete...
What is the current status of trial NCT00065845?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 322 participants. The study started on 2002-04. Estimated completion is 2007-04.
What conditions does trial NCT00065845 study?
This clinical trial studies the following conditions: Uterine Prolapse, Vaginal Prolapse, Urinary Incontinence, Stress.
What interventions are being tested in trial NCT00065845?
The interventions under investigation include: Burch urethropexy at time of sacrocolpopexy (PROCEDURE).
Who is sponsoring clinical trial NCT00065845?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00065845 being conducted?
This trial has 7 study locations across Alabama, Illinois, Iowa, Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.